EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC 4.0

Circadian rhythms and chronotherapy in Alzheimer's disease: Mechanisms and therapeutic implications

Bivek Singh iD, Filippo Pigazzani iD, Roberto Manfredini iD

Neuroprotection · 2026-09 · 4 (3) · 229-247

DOI: 10.1002/nep3.70046 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Neuroprotection, online erschienen am 16.07.2026. Verfasst von Bivek Singh und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology Shanghai East Hospital, Tongji University School of Medicine Shanghai China. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 128 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Alzheimer's disease (AD), the most prevalent form of dementia, has been increasingly associated with disruptions in circadian rhythms and sleep–wake regulation. This narrative review synthesizes recent literature on how circadian dysfunction may contribute to AD pathogenesis, biomarker profiles, and treatment response. Mechanistic studies suggest important interactions between core clock genes and neurodegenerative cascades involving oxidative stress, neuroinflammation, glial reactivity, and proteostasis. Disruptions in circadian‐regulated molecular pathways, including brain and muscle ARNT‐like 1 ( BMAL1 )–sirtuin 1 ( SIRT1 ), nuclear factor kappa B ( NF‐κB )–NOD‐like receptor family pyrin domain containing 3 ( NLRP3 ), and period circadian regulator 2 ( PER2 )–antioxidant signaling pathways, may compromise neuronal resilience and worsen AD‐related pathology. Emerging evidence also suggests distinct circadian patterns in AD‐relevant biomarkers, including melatonin, cortisol, orexin, core body temperature, blood–brain barrier permeability, and glial marker oscillations. These rhythmic patterns may have diagnostic and prognostic relevance and support the need for time‐aware biomarker interpretation. Chronotherapeutic strategies targeting circadian biology, including melatonin receptor agonists, light therapy, time‐restricted feeding, and circadian‐aligned drug delivery systems, may help improve targeted clinical endpoints in AD. This review also discusses chronoepigenetics as an emerging area in which clock‐regulated epigenetic modifications may influence neurodegenerative trajectories. Future directions include next‐generation chronotherapeutic targets, such as glial clocks, clock‐gated inflammatory mechanisms, and systemic comorbidities with circadian modulation, including diabetes and hypertension. Overall, the available evidence supports a close association between circadian disruption and both AD pathology and therapeutic response, while also highlighting important gaps in large‐scale clinical trials. This time‐oriented perspective may support the development of personalized, biomarker‐guided, and rhythm‐informed approaches to AD care. By bridging chronobiology and neurodegeneration, this review highlights how circadian precision medicine may refine future approaches to understanding and managing AD.

Schlagwörter

Stichwörter der Autor:innen

Alzheimer diseasebiomarkerschronobiologychronotherapycircadian rhythm

Autor:innen und Institutionen

  • Department of Neurology Shanghai East Hospital, Tongji University School of Medicine Shanghai China.
  • International Medical School and Postgraduate Centre Management and Science University Shah Alam Selangor Darul Ehsan Malaysia.
  • Division of Cardiovascular Research School of Medicine University of Dundee Dundee UK.
  • Department of Medical Sciences University Strategic Center for Studies on Gender Medicine University of Ferrara Ferrara Italy.

ORCID-Profile: Bivek Singh, Filippo Pigazzani, Roberto Manfredini

Zitieren

APA

Singh, B., Pigazzani, F., & Manfredini, R. (2026). Circadian rhythms and chronotherapy in Alzheimer's disease: Mechanisms and therapeutic implications. Neuroprotection, 4(3), 229-247. https://doi.org/10.1002/nep3.70046

Vancouver

Singh B, Pigazzani F, Manfredini R. Circadian rhythms and chronotherapy in Alzheimer's disease: Mechanisms and therapeutic implications. Neuroprotection. 2026;4(3):229-247. doi:10.1002/nep3.70046

BibTeX
@article{Singh2026,
  author = {Singh, Bivek and Pigazzani, Filippo and Manfredini, Roberto},
  title = {Circadian rhythms and chronotherapy in Alzheimer's disease: Mechanisms and therapeutic implications},
  journal = {Neuroprotection},
  year = {2026},
  volume = {4},
  number = {3},
  pages = {229--247},
  doi = {10.1002/nep3.70046}
}
Kostenlos starten →